BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33153806)

  • 1. Contrast-Enhanced Ultrasonography versus Contrast-Enhanced Magnetic Resonance Imaging in the Diagnosis of Mediastinal Tumors.
    Pan J; Chen W; Zhang H; Huang X; Huang X
    Ultrasound Med Biol; 2021 Feb; 47(2):261-271. PubMed ID: 33153806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound.
    Friedrich-Rust M; Glasemann T; Polta A; Eichler K; Holzer K; Kriener S; Herrmann E; Nierhoff J; Bon D; Bechstein WO; Vogl T; Zeuzem S; Bojunga J
    Ultraschall Med; 2011 Oct; 32(5):460-71. PubMed ID: 21667434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
    Bröker MEE; Taimr P; de Vries M; Braun LMM; de Man RA; Ijzermans JNM; Dwarkasing RS
    AJR Am J Roentgenol; 2020 Jan; 214(1):81-89. PubMed ID: 31573852
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
    Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
    Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
    Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
    Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
    Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
    Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.
    Pei XQ; Liu LZ; Xiong YH; Zou RH; Chen MS; Li AH; Cai MY
    Br J Radiol; 2013 Mar; 86(1023):20120536. PubMed ID: 23392189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
    Tselikas L; Pigneur F; Roux M; Baranes L; Costentin C; Roche V; Calderaro J; Herin E; Laurent A; Zafrani E; Azoulay D; Mallat A; Rahmouni A; Luciani A
    Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI.
    Caproni N; Marchisio F; Pecchi A; Canossi B; Battista R; D'Alimonte P; Torricelli P
    Eur Radiol; 2010 Jun; 20(6):1384-95. PubMed ID: 20033178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrast enhanced ultrasound and magnetic resonance imaging in hepatocellular carcinoma diagnosis.
    Dumitrescu CI; Gheonea IA; Săndulescu L; Surlin V; Săftoiu A; Dumitrescu D
    Med Ultrason; 2013 Dec; 15(4):261-7. PubMed ID: 24286088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of contrast-enhanced ultrasound in the characterization of vascular pattern of solid pancreatic lesions.
    Ardelean M; Sirli R; Sporea I; Bota S; Danila M; Popescu A; Timar B; Buzas R; Mazilu O; Ardelean O; Lighezan D
    Med Ultrason; 2015 Mar; 17(1):16-21. PubMed ID: 25745652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study.
    Poanta L; Serban O; Pascu I; Pop S; Cosgarea M; Fodor D
    Med Ultrason; 2014 Mar; 16(1):7-14. PubMed ID: 24567918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) in the evaluation of unclear solid renal lesions.
    Rübenthaler J; Paprottka K; Marcon J; Hameister E; Hoffmann K; Joiko N; Reiser M; Clevert DA
    Clin Hemorheol Microcirc; 2016; 64(4):757-763. PubMed ID: 27767985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.